Evidence map›Paper›PMID 25122788›Full record

ArticleJournal of virology2014

Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants.

Yoko Matsuzaki, Kanetsu Sugawara, Mina Nakauchi, Yoshimasa Takahashi, Taishi Onodera, Yasuko Tsunetsugu-Yokota, Takayuki Matsumura, Manabu Ato, Kazuo Kobayashi, Yoshitaka Shimotai and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. An outbreak of influenza A(H1N1)pdm09 antigenic variants exhibiting cross-resistance to oseltamivir and peramivir in an elementary school in Japan, September 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Yoko MatsuzakiDepartment of Infectious Diseases, Yamagata University Faculty of Medicine, Yamagata, Japan.
Kanetsu SugawaraDepartment of Infectious Diseases, Yamagata University Faculty of Medicine, Yamagata, Japan.
Mina NakauchiInfluenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yoshimasa TakahashiDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Taishi OnoderaDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Yasuko Tsunetsugu-YokotaDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Takayuki MatsumuraDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Manabu AtoDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Kazuo KobayashiDepartment of Immunology, National Institute of Infectious Diseases, Tokyo, Japan.
Yoshitaka ShimotaiDepartment of Infectious Diseases, Yamagata University Faculty of Medicine, Yamagata, Japan.
Katsumi MizutaDepartment of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan.
Seiji HongoDepartment of Infectious Diseases, Yamagata University Faculty of Medicine, Yamagata, Japan.
Masato TashiroInfluenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Eri NobusawaInfluenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan nobusawa@nih.go.jp.
National Institute of Infectious Diseases · JPYamagata University · JPYamagata Prefectural Institute of Public Health · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledWe determined the antigenic structure of pandemic influenza A(H1N1)pdm09 virus hemagglutinin (HA) using 599 escape mutants that were selected using 16 anti-HA monoclonal antibodies (MAbs) against A/Narita/1/2009. The sequencing of mutant HA genes revealed 43 amino acid substitutions at 24 positions in three antigenic sites, Sa, Sb, and Ca2, which were previously mapped onto A/Puerto Rico/8/34 (A/PR/8/34) HA (A. J. Caton, G. G. Brownlee, J. W. Yewdell, and W. Gerhard, Cell 31:417-427, 1982), and an undesignated site, i.e., amino acid residues 141, 142, 143, 171, 172, 174, 177, and 180 in the Sa site, residues 170, 173, 202, 206, 210, 211, and 212 in the Sb site, residues 151, 154, 156, 157, 158, 159, 200, and 238 in the Ca2 site, and residue 147 in the undesignated site (numbering begins at the first methionine). Sixteen MAbs were classified into four groups based on their cross-reactivity with the panel of escape mutants in the hemagglutination inhibition test. Among them, six MAbs targeting the Sa and Sb sites recognized both residues at positions 172 and 173. MAb n2 lost reactivity when mutations were introduced at positions 147, 159 (site Ca2), 170 (site Sb), and 172 (site Sa). We designated the site consisting of these residues as site Pa. From 2009 to 2013, no antigenic drift was detected for the A(H1N1)pdm09 viruses. However, if a novel variant carrying a mutation at a position involved in the epitopes of several MAbs, such as 172, appeared, such a virus would have the advantage of becoming a drift strain. IMPORTANCE: The first influenza pandemic of the 21st century occurred in 2009 with the emergence of a novel virus originating with swine influenza, A(H1N1)pdm09. Although HA of A(H1N1)pdm09 has a common origin (1918 H1N1) with seasonal H1N1, the antigenic divergence of HA between the seasonal H1N1 and A(H1N1)pdm09 viruses gave rise to the influenza pandemic in 2009. To take precautions against the antigenic drift of the A(H1N1)pdm09 virus in the near future, it is important to identify its precise antigenic structure. To obtain various mutants that are not neutralized by MAbs, it is important to neutralize several plaque-cloned parent viruses rather than only a single parent virus. We characterized 599 escape mutants that were obtained by neutralizing four parent viruses of A(H1N1)pdm09 in the presence of 16 MAbs. Consequently, we were able to determine the details of the antigenic structure of HA, including a novel epitope.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, ViralEpitope MappingHemagglutination Inhibition TestsHemagglutinin Glycoproteins, Influenza VirusInfluenza A Virus, H1N1 SubtypeMice, Inbred BALB CMolecular Sequence DataMutant ProteinsRNA, ViralSelection, GeneticSequence Analysis, DNAVirus CultivationAntibodies, MonoclonalAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusMutant ProteinsRNA, Viral

Identifiers

PMID25122788
PMCPMC4248900
OpenAlexW1978976903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.